SNSE CIK: 1829802

Sensei Biotherapeutics, Inc. (SNSE)

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−37.5
FY22:
−50.2
FY23:
−37.1
FY24:
−32.6
FY25:
−22.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.0
FY22:
−47.0
FY23:
−32.3
FY24:
–
FY25:
−20.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.8
FY22:
−48.6
FY23:
−34.1
FY24:
−30.2
FY25:
−21.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.8
FY22:
−48.6
FY23:
−34.1
FY24:
−30.2
FY25:
−21.1

All amounts in millions USD Data sources:SEC EDGARTwelve Data